当前位置:首页 > 毕马威 >

毕马威:仿制药2030-抑制下降趋势的三种策略

  • 2021年07月15日
  • 50 金币

20301CAGR5.7%CAGR5.4%278367497290%85%84%84%81%73%68%67%48%34%28%22%3▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪2021202320252020202220242026▪▪▪▪▪▪▪▪▪▪▪▪19.6%18.7%11.0% 7.2% 5.4% 5.4%30.1%4WBADRed OakClarusONE21%9%37% 34%CVS Caremark / Aetna OptumRxHumana Pharmacy MedImpact Healthcare7% 6%11%30% 23% 23%519.9% 17.3%14.7% 12.8%62.9%40.3%45.9%6▪▪▪▪ ▪788• •9• • •10• • • •12.1% 88.944.840.0%51.2%46.5%54.1%47.4%52.6%33.6%41.3%1175 6345454% 3% 11%41% 41%• • • •12CAGR13.8%4.7 1.9CAGR36.0%8.61.03843382827713• •141516• • • • • • • • •• • • • •• •• • • •1718

  • 关注微信

猜你喜欢